Literature DB >> 31517807

Prevalence of Trichomonas vaginalis Among Civilian, Noninstitutionalized Male and Female Population Aged 14 to 59 Years: United States, 2013 to 2016.

Elaine W Flagg1, Elissa Meites, Christi Phillips, John Papp, Elizabeth A Torrone.   

Abstract

Among the US civilian noninstitutionalized population aged 14 to 59 years in 2013 to 2016, prevalence of Trichomonas vaginalis infection in urine was 1.3% overall. Prevalence was 2.1% among females, 0.5% among males, and highest at 9.6% among non-Hispanic black females. Estimate instability limited analysis of factors beyond sex, age, and race/Hispanic ethnicity.

Entities:  

Mesh：

Year:  2019        PMID： 31517807      PMCID： PMC6924265          DOI： 10.1097/OLQ.0000000000001013

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  12 in total

1.  National Health and Nutrition Examination Survey: Estimation Procedures, 2011-2014.

Authors:  Te-Ching Chen; Jennifer D Parker; Jason Clark; Hee-Choon Shin; Jennifer R Rammon; Vicki L Burt
Journal:  Vital Health Stat 2       Date:  2018-01

2.  Readily treatable reproductive tract infections and preterm birth among black women.

Authors:  Janice I French; James A McGregor; Ruth Parker
Journal:  Am J Obstet Gynecol       Date:  2006-06       Impact factor: 8.661

3.  Urinary Meatal Swabbing Detects More Men Infected With Mycoplasma genitalium and Four Other Sexually Transmitted Infections Than First Catch Urine.

Authors:  Max Chernesky; Dan Jang; Marek Smieja; Manuel Arias; Irene Martin; Barbara Weinbaum; Damon Getman
Journal:  Sex Transm Dis       Date:  2017-08       Impact factor: 2.830

4.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

5.  Prevalence and Correlates of Trichomonas vaginalis Infection Among Men and Women in the United States.

Authors:  Eshan U Patel; Charlotte A Gaydos; Zoe R Packman; Thomas C Quinn; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

6.  Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.

Authors:  Melinda B Nye; Jane R Schwebke; Barbara A Body
Journal:  Am J Obstet Gynecol       Date:  2009-02       Impact factor: 8.661

7.  Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic.

Authors:  K A Wendel; E J Erbelding; C A Gaydos; A M Rompalo
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

8.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

9.  Prevalence of Trichomonas vaginalis Infection Among US Males, 2013-2016.

Authors:  Michael Daugherty; Kendall Glynn; Timothy Byler
Journal:  Clin Infect Dis       Date:  2019-01-18       Impact factor: 9.079

10.  Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys.

Authors:  D Z Kounali; N J Welton; K Soldan; S C Woodhall; J Kevin Dunbar; S J Migchelsen; C H Mercer; P Horner; A E Ades
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451
View more
  7 in total

1.  In vitro and in silico trichomonacidal activity of 2,8-bis(trifluoromethyl) quinoline analogs against Trichomonas vaginalis.

Authors:  Mirna Samara Dié Alves; Ângela Sena-Lopes; Raquel Nascimento das Neves; Angela Maria Casaril; Micaela Domingues; Paloma Taborda Birmann; Emerson Teixeira da Silva; Marcus Vinicius Nora de Souza; Lucielli Savegnago; Sibele Borsuk
Journal:  Parasitol Res       Date:  2022-07-20       Impact factor: 2.383

2.  Clinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections.

Authors:  Barbara Van Der Pol; Edith Torres-Chavolla; Salma Kodsi; Charles K Cooper; Thomas E Davis; Kenneth H Fife; Stephanie N Taylor; Michael H Augenbraun; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2021-02-01       Impact factor: 3.868

3.  Bacterial Vaginosis and Its Association With Incident Trichomonas vaginalis Infections: A Systematic Review and Meta-Analysis.

Authors:  Arlene C Seña; Linda A Goldstein; Gilbert Ramirez; Austin J Parish; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

4.  Incarceration and Subsequent Pregnancy Loss: Exploration of Sexually Transmitted Infections as Mediating Pathways.

Authors:  Joy D Scheidell; Typhanye V Dyer; Andrea K Knittel; Ellen C Caniglia; Lorna E Thorpe; Andrea B Troxel; Carl W Lejuez; Maria R Khan
Journal:  J Womens Health (Larchmt)       Date:  2021-05-28       Impact factor: 3.017

5.  Estimating the Direct Medical Outpatient Costs of Diagnosis and Treatment of Trichomoniasis Among Commercially Insured Patients in the United States, 2016 to 2018.

Authors:  Sagar Kumar; Harrell Chesson; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2021-03-01       Impact factor: 3.868

6.  Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness.

Authors:  Haywood Brown; Madeline Drexler
Journal:  Popul Health Manag       Date:  2020-10       Impact factor: 2.459

7.  Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.

Authors:  Christina A Muzny; Jane R Schwebke; Paul Nyirjesy; Gregory Kaufman; Leandro A Mena; Gweneth B Lazenby; Olivia T Van Gerwen; Keonte J Graves; Janeen Arbuckle; Belvia A Carter; Connette P McMahon; Scott Eder; Jackie Shaw; Brajesh Pandey; Steven E Chavoustie
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.